1,025 followers
RRM1 predicts clinical outcome of high-and intermediate-risk non-muscle-invasive bladder cancer patients treated with intravesical gemcitabine monotherapy https://t.co/Q4Ctcz2yyG via @BioMedCentral #OpenAccess
RRM1 predicts clinical outcome of high-and intermediate-risk non-muscle-invasive bladder cancer patients treated with intravesical gemcitabine monotherapy https://t.co/Q4Ctcz2yyG via @BioMedCentral #OpenAccess